Skip to main content

Site notifications

CSL Behring (Australia) Pty Ltd

Regulatory activities for this sponsor.

Sponsor content

2 result(s) found, displaying 1 to 2
  • Hemgenix (etranacogene dezaparvovec), a gene therapy, has been approved for the treatment of haemophilia B (congenital factor IX deficiency) in adults.

Help us improve this page